Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Lancaster Resources Inc. Share Issue/Capital Change 2023

Jan 20, 2023

47911_rns_2023-01-19_d8a8909c-5ada-4ef4-8a15-a836c28ba2c8.pdf

Share Issue/Capital Change

Open in viewer

Opens in your device viewer

==> picture [612 x 91] intentionally omitted <==

January 19, 2023

Delivered by SEDAR

BC Securities Commission Alberta Securities Commission Saskatchewan Securities Commission Manitoba Securities Commission Ontario Securities Commission The Canadian Depository for Securities Canadian Securities Exchange

Dear Sirs/Mesdames

Re: NeonMind Biosciences Inc. (the “Company”) Proposed 30 for 1 Share Consolidation and Confirmation of Record Date – January 25, 2023

The Company has its common shares (the “ Shares ”) listed and trading on the Canadian Securities Exchange (the “ CSE ”). The Company’s ISIN number of the Shares is currently CA64051V3039 and its CUSIP number is 64051V303.

Pursuant to Policy 9 – Name Change, Stock Splits & Share Consolidations of the CSE, please be advised that on January 25, 2023, the record date, the Company will consolidate its common shares (“ Shares ”) on the basis of one (1) post-consolidation Share for every thirty (30) pre-consolidation Shares (the “ Consolidation ”).

The ISIN number of the post-Consolidation Shares will be CA64051V4029 and the CUSIP number will be 64051V402.

We trust you will find the foregoing to be in order, however if you have any questions or concerns, please feel free to contact the undersigned.

Yours truly,

NEONMIND BIOSCIENCES INC.

Per: “Rob Tessarolo”

Rob Tessarolo CEO and President